We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05011058
Brief Title: An Open-Label, Phase 2 Trial of Nanatinostat in Combination With Valganciclovir in Patients With Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas (NAVAL-1)

First Submitted : August 2, 2021
First Submitted that Met QC Criteria : August 11, 2021
First Posted : August 18, 2021

Last Update Submitted that Met QC Criteria : January 31, 2023
Last Update Posted : February 1, 2023